Victory Capital Management Inc Aclaris Therapeutics, Inc. Transaction History

Victory Capital Management Inc

  • $153 Billion
  • Q3 2025

A detailed history of Victory Capital Management Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 10,628 shares of ACRS stock, worth $26,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,628
Previous 11,004 3.42%
Holding current value
$26,782
Previous $15,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$1.41 - $2.13 $530 - $800
-376 Reduced 3.42%
10,628 $20,000
Q2 2025

Aug 13, 2025
SELL
$1.08 - $1.63 $5 - $8
-5 Reduced 0.05%
11,004 $15,000
Q1 2025

May 02, 2025
BUY
$1.53 - $2.6 $16,843 - $28,623
11,009 New
11,009 $16,000
Q1 2022

May 04, 2022
SELL
$9.74 - $17.92 $220,611 - $405,888
-22,650 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$12.27 - $18.49 $140,565 - $211,821
-11,456 Reduced 33.59%
22,650 $329,000
Q3 2021

Nov 02, 2021
BUY
$13.38 - $18.8 $217,853 - $306,101
16,282 Added 91.35%
34,106 $614,000
Q2 2021

Aug 03, 2021
BUY
$17.08 - $29.6 $166,461 - $288,481
9,746 Added 120.65%
17,824 $313,000
Q1 2021

May 04, 2021
BUY
$5.86 - $27.73 $47,337 - $224,002
8,078 New
8,078 $204,000
Q2 2020

Aug 07, 2020
SELL
$1.04 - $1.73 $6,584 - $10,952
-6,331 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$0.75 - $2.18 $36 - $104
-48 Reduced 0.75%
6,331 $7,000
Q4 2019

Feb 04, 2020
SELL
$1.02 - $1.97 $541 - $1,046
-531 Reduced 7.68%
6,379 $8,000
Q3 2019

Nov 12, 2019
BUY
$0.79 - $2.47 $5,458 - $17,067
6,910 New
6,910 $7,000
Q2 2019

Aug 15, 2019
SELL
$2.13 - $7.06 $217,794 - $721,892
-102,251 Closed
0 $0
Q1 2019

May 03, 2019
BUY
$5.63 - $7.84 $168,731 - $234,964
29,970 Added 41.46%
102,251 $612,000
Q4 2018

Feb 05, 2019
SELL
$6.3 - $15.4 $8,505 - $20,790
-1,350 Reduced 1.83%
72,281 $534,000
Q3 2018

Nov 01, 2018
SELL
$14.38 - $20.89 $53,781 - $78,128
-3,740 Reduced 4.83%
73,631 $1.07 Million
Q2 2018

Aug 02, 2018
SELL
$16.46 - $20.33 $67,815 - $83,759
-4,120 Reduced 5.06%
77,371 $1.55 Million
Q1 2018

May 04, 2018
BUY
$17.08 - $25.64 $136,469 - $204,863
7,990 Added 10.87%
81,491 $1.43 Million
Q4 2017

Feb 01, 2018
BUY
$21.47 - $27.8 $306,806 - $397,262
14,290 Added 24.13%
73,501 $1.81 Million
Q3 2017

Oct 27, 2017
BUY
$23.02 - $28.8 $418,733 - $523,872
18,190 Added 44.34%
59,211 $1.53 Million
Q2 2017

Aug 07, 2017
BUY
N/A
41,021
41,021 $1.11 Million

Others Institutions Holding ACRS

# of Institutions
107
Shares Held
81.7M
Call Options Held
0
Put Options Held
0
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $168M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email